Product Information

AMILORIDE HCL-HYDROCHLOROTHIAZIDE 5-50 MG TAB is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.4547 per EA under NDC 00555048305. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on May 10, 1988. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMILORIDE HCL-HYDROCHLOROTHIAZIDE 5-50 MG TAB

Amiloride Hydrochloride and Hydrochlorothiazide
$0.4547per EA

Strength

5; 50 mg/1; mg/1

NDC

00555048305

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA071111

FDA Approved

5/10/1988

TE Code

AB

On Market Since

12/1/1989

Pharmacological Classes

Decreased Renal K+ Excretion
Increased Diuresis
Increased Diuresis
Potassium-sparing Diuretic
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for AMILORIDE HCL-HYDROCHLOROTHIAZIDE 5-50 MG TAB has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 76.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4547 per EA
All-time high$0.4569 (Aug 12, 2026)
All-time low$0.2497 (Apr 23, 2014)
52-week high$0.4569
52-week low$0.4381
Median price$0.3823
Average price$0.3858
Largest weekly change+23.2% (Jun 25, 2014)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-0.5%

1M

-0.5%

3M

+1.5%

6M

+3.4%

1Y

+1.2%

3Y

+2.6%

5Y

+26.7%

All

+76.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMILORIDE HCL-HYDROCHLOROTHIAZIDE 5-50 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for AMILORIDE HCL-HYDROCHLOROTHIAZIDE 5-50 MG TAB, manufactured by Teva Pharmaceuticals USA Inc., is $0.4547 per EA (NDC 00555048305), effective Aug 19, 2026.

How has the price of AMILORIDE HCL-HYDROCHLOROTHIAZIDE 5-50 MG TAB changed over time?

Over the history we have for it, the NADAC for AMILORIDE HCL-HYDROCHLOROTHIAZIDE 5-50 MG TAB has risen 76.6%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for AMILORIDE HCL-HYDROCHLOROTHIAZIDE 5-50 MG TAB?

Since Nov 28, 2013, the NADAC for AMILORIDE HCL-HYDROCHLOROTHIAZIDE 5-50 MG TAB has ranged from a low of $0.2497 (Apr 23, 2014) to a high of $0.4569 (Aug 12, 2026), with a median of $0.3823 per EA.

Are there cheaper alternatives to AMILORIDE HCL-HYDROCHLOROTHIAZIDE 5-50 MG TAB?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMILORIDE HCL-HYDROCHLOROTHIAZIDE 5-50 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures AMILORIDE HCL-HYDROCHLOROTHIAZIDE 5-50 MG TAB?

AMILORIDE HCL-HYDROCHLOROTHIAZIDE 5-50 MG TAB (NDC 00555048305) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.